Stocktoria

NEUROCRINE BIOSCIENCES INC NBIX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1996-05-23 · LEI

NEUROCRINE BIOSCIENCES INC statistics & valuation

Market cap$16.9B
P / E35.4×
P / S5.9×
P / B5.2×
P / FCF22.6×
Net margin16.7%
Return on equity14.7%
FCF margin26.2%
Return on capital15.9%
Graham number -63.1%$57.75

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($57.75); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-940.60% -88.20% 4.70% 4.70% 38.90% 7.90% 10.40% 13.20% 14.50% 16.70% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-982.50% -81.30% 8.20% 9.20% 15.60% 9.00% 16.70% 13.30% 24.20% 21.60% 2016201720182019202020212022202320242025
Return on equity (%)
-44.80% -38.30% 4.40% 5.80% 36.20% 6.50% 9.00% 11.20% 13.20% 14.70% 2016201720182019202020212022202320242025
Shares outstanding
86.9M 88.8M 95.4M 95.7M 97.8M 97.9M 98.9M 101.0M 103.7M 102.5M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-38.60% -17.40% 2.10% 2.80% 23.50% 4.30% 6.50% 7.70% 9.20% 10.30% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-735.30% -62.70% 17.00% 16.80% 20.80% 20.60% 21.70% 19.20% 23.70% 26.20% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$1.63 -$1.62 $0.22 $0.39 $4.16 $0.92 $1.56 $2.47 $3.29 $4.67 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

NEUROCRINE BIOSCIENCES INC trades at about 33.5× earnings — below its 10-year norm (10-year range 13.9×–401×, median 71.1×).

13.9× 401×

Shaded band = 10-year range (13.9×–401×); dot = today's 33.5×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin21.6%24.2%13.3%16.7%9.0%15.6%9.2%8.2%-81.3%-982.5%
Net margin16.7%14.5%13.2%10.4%7.9%38.9%4.7%4.7%-88.2%-940.6%
FCF margin26.2%23.7%19.2%21.7%20.6%20.8%16.8%17.0%-62.7%-735.3%
Return on assets10.3%9.2%7.7%6.5%4.3%23.5%2.8%2.1%-17.4%-38.6%
Return on equity14.7%13.2%11.2%9.0%6.5%36.2%5.8%4.4%-38.3%-44.8%
Current ratio3.393.402.452.703.965.451.478.3610.2010.21

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.